WO2013012302A3 - Elaboration d'un sirop anti-inflammatoire/anti-œdemateux naturel a base d'extraits aqueux de plantes originaires du sud-est du maroc - Google Patents

Elaboration d'un sirop anti-inflammatoire/anti-œdemateux naturel a base d'extraits aqueux de plantes originaires du sud-est du maroc Download PDF

Info

Publication number
WO2013012302A3
WO2013012302A3 PCT/MA2012/000012 MA2012000012W WO2013012302A3 WO 2013012302 A3 WO2013012302 A3 WO 2013012302A3 MA 2012000012 W MA2012000012 W MA 2012000012W WO 2013012302 A3 WO2013012302 A3 WO 2013012302A3
Authority
WO
WIPO (PCT)
Prior art keywords
inflammatory
syrup
inflammation
plants
indomethacin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/MA2012/000012
Other languages
English (en)
Other versions
WO2013012302A2 (fr
Inventor
Dalila BOUSTA
Latifa EL MANSOURI
Ennabili ABDESLAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sidi Mohamed Ben Abdellah University
Original Assignee
Sidi Mohamed Ben Abdellah University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sidi Mohamed Ben Abdellah University filed Critical Sidi Mohamed Ben Abdellah University
Publication of WO2013012302A2 publication Critical patent/WO2013012302A2/fr
Anticipated expiration legal-status Critical
Publication of WO2013012302A3 publication Critical patent/WO2013012302A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282—Artemisia, e.g. wormwood or sagebrush
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534—Mentha (mint)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention, concerne l'élaboration d'un phytomédicament anti- inflammatoire traditionnel amélioré sous forme de sirop 100% naturel à base de cinq plantes médicinales récoltées dans la région de Rissani-Errachidia (Sud-est du Maroc). Ce phytomédicament est obtenu par macération aqueuse à froid de cinq plantes (Rosmarinus officinalis L., Phoenix dactylifera L., Artemisia herba-alba Asso, Mentha pulegium L., Mentha suaveolens Ehrh.) sélectionnées soigneusement à la base d'enquêtes ethnopharmacologiques dans la région susmentionnée, et formulées sous forme de sirop. Dans un premier temps, le macérât aqueux des plantes sélectionnées, dosé à lg/kg de poids corporel (p.c) du rat Wistar est évalué par voie orale; le pourcentage d'inhibition de l'inflammation est de l'ordre de 82.98 %, en comparaison avec l'indométacine 61.7%, 5 heures après l'induction de l'inflammation à la carragénine 0.5 %. Le pouvoir anti- inflammatoire du sirop formulé à lg/kg p.c. a été également évalué par voie orale chez les rats Wistar. Nous avons noté un important pouvoir anti-inflammatoire de l'ordre de 84.04 %, en comparaison avec l'indométacine, 5 heures après l'induction de l'inflammation. Ce sirop est un anti-inflammatoire 100 % naturel, plus puissant que l'indométacine; il est élaboré à partir de plantes à usage traditionnel reconnu. A ce titre, il participe à l'amélioration de la qualité de vie et au bien être dans le cas d'inflammation.
PCT/MA2012/000012 2011-07-15 2012-06-26 Elaboration d'un sirop anti-inflammatoire/anti-œdemateux naturel a base d'extraits aqueux de plantes originaires du sud-est du maroc Ceased WO2013012302A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MA34033 2011-07-15
MA34033A MA33970B1 (fr) 2011-07-15 2011-07-15 Elaboration d'un sirop anti-inflammatoire naturel à base d'extraits aqueux de plantes originaires du sud-est du Maroc

Publications (2)

Publication Number Publication Date
WO2013012302A2 WO2013012302A2 (fr) 2013-01-24
WO2013012302A3 true WO2013012302A3 (fr) 2014-05-08

Family

ID=47558648

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MA2012/000012 Ceased WO2013012302A2 (fr) 2011-07-15 2012-06-26 Elaboration d'un sirop anti-inflammatoire/anti-œdemateux naturel a base d'extraits aqueux de plantes originaires du sud-est du maroc

Country Status (2)

Country Link
MA (1) MA33970B1 (fr)
WO (1) WO2013012302A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10004778B1 (en) 2017-05-25 2018-06-26 Sultan Qaboos University Method of making an Ajwa date-based treatment for snake envenomation
CH715443B1 (fr) * 2018-10-11 2020-12-30 Mytamar Gmbh Extrait purifié et concentré de polyphénols issu des fruits du palmier dattier Phoenix dactylifera.

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HEILWEIL M F ET AL: "TESTING ELECTROMAGNETIC SWITCHING DEVICES", IBM TECHNICAL DISCLOSURE BULLETIN,, vol. 9, no. 4, 1 September 1966 (1966-09-01), pages 367, XP001608322 *
LATIFA EL MANSOURI ET AL: "Phytochemical screening and anti-inflammatory property of one recipe from moroccan traditional medicine", INTERNATIONAL JOURNAL OF PHYTOPHARMACOLOGY,, vol. 5, no. 2, 1 January 2014 (2014-01-01), pages 76 - 84, XP009176893 *
LATIFA EL MANSOURI ET AL: "Socioeconomic interest and valorization of medicinal plants from the Rissani oasis (SE of Morocco)[Interés socioeconómico y valorización de plantas medicinales del oasis de Rissani (SE de Marruecos)]", BOLETÍN LATINOAMERICANO Y DEL CARIBE DE PLANTAS MEDICINALES Y AROMÁTICAS, vol. 10, no. 1, 1 January 2011 (2011-01-01), pages 30 - 45, XP055107858, ISSN: 0717-7917 *

Also Published As

Publication number Publication date
MA33970B1 (fr) 2013-02-01
WO2013012302A2 (fr) 2013-01-24

Similar Documents

Publication Publication Date Title
Sarkar et al. Ameliorative effects of oleanolic acid on fluoride induced metabolic and oxidative dysfunctions in rat brain: experimental and biochemical studies
ZA202006137B (en) Substituted imidazolidin-2-one derivatives as prmt5 inhibitors
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
WO2012082718A3 (fr) 3-méthanesulfonylpropionitrile pour le traitement d'une inflammation et de la douleur
EA201171216A1 (ru) Фенилацетат l-орнитина и способы его получения
UA107100C2 (xx) Конденсовані гетероароматичні піролідинони як інгібітори syk
EA201270824A1 (ru) Соединения для уменьшения продукции бета-амилоида
BR112013002601A2 (pt) corticosteróides para o tratamento de dor em articulação
SG10201902370QA (en) Compositions and methods of use of phorbol esters
MX386256B (es) Derivados de acido oleanolico modificado en c4 para la inhibicion de il-17 y otros usos.
NI201400022A (es) Composición farmacéutica que comprende un ciclopolisacárido
WO2008155592A3 (fr) Composition liposomale
WO2011029547A8 (fr) Dérivés d'isoxazolidine
IT1397734B1 (it) Uso di estratti naturali di tannini e non tannini atti a migliorare la fertilita' del suolo e determinare un effetto starter sulle colture, e fitocomplesso di tannini e di non tannini per tale uso.
WO2016056026A3 (fr) Composition synergique pour l'arthrose
WO2012123482A3 (fr) Dérivés d'isoxazolidine
BR112015007830A2 (pt) aumento do rendimento para plantas suscetíveis ao estresse
GB201117490D0 (en) Anti-inflammatory compounds
WO2011022393A3 (fr) Inhibiteurs de protéine de transfert de la phosphatidylcholine
WO2011049979A3 (fr) Formulations injectables pour administration intra-articulaire ou péri-articulaire
WO2017220050A3 (fr) Composition pharmaceutique d'azithromycine et son utilisation médicale pour soulager la toux
WO2011060253A3 (fr) Méthodes de traitement de maladies, composés pharmaceutiques, compositions et formes pharmaceutiques
CO6280404A2 (es) Proceso de obtencion de un extracto estandarizado a partir de una planta del genero aleurites, extrcto obtenido y composicion farmaceutica que comprende dicho extracto
MX2018011142A (es) Combinacion farmaceutica sinergica de un inhibidor selectivo de la ciclooxigenasa 2 y un derivado de antraquinona.
WO2010143825A3 (fr) Agent antiarthritique à l'aide de cyathula officinalis

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 12814401

Country of ref document: EP

Kind code of ref document: A2